About CSL Biotherapies

Reliability — Safety — Quality — Heritage

CSL Biotherapies understands the influenza vaccine business and customers’ needs for reliable and safe flu vaccine supplies. Our long-established parent, CSL Limited, has been producing flu vaccine without disruption for nearly four decades. Based in Melbourne, Australia, CSL provides flu vaccine to Australia, New Zealand, and more than 16 countries in Europe, South America and Asia.

Beginning with the 2007 season, CSL Biotherapies plans to contribute to meeting the United States’ growing demand for reliable supplies of flu vaccine each year. CSL Biotherapies is ideally positioned to become a reliable resource for health care professionals who actively embrace the U.S. government’s flu immunization recommendations.

Millions of people outside the United States already rely on CSL for their flu vaccine. CSL Biotherapies will offer several competitive advantages to health care professionals in search of timely delivery of high-quality flu vaccines.

Download the CSL Biotherapies Brochure (.pdf)